PASC (N=17) median (range) Controls (N=13) median (range)
p value
Blood parameters Blood parameters Blood parameters Blood parameters Blood parameters
BMI (kg/m2) 18 (14.3-23.7) 19 (13-26) p=0.669
Leukocytes/nl 6.44 (4.13-11.42) 5.73 (4.73-9.29) p=0.426
Hb (g/dl) 13 (11-14.5) 13.4 (11-15.4) p=0.836
Thrombocytes/nl 291 (189-465) 270.5 (226-351) p=0.967
Creatinine (μmol/l) 55 (18-78) 48 (35-72) p=0.095
AST/GOT (U/l) 23 (12-34) 27 (17-36) p=0.094
ALT/GPT (U/l) 18 (9-30) 19 (9-36) p=0.503
γ-GT (U/l) 13 (7-24) 14 (12-19) p=0.205
Creatine Kinase (U/l) 101 (15-230) 153 (113-253) p=0.011
Ddimers (mg/l) 0.22 (0.19-0.54) 0.2 (0.2-0.6) p=0.802
CRP (mg/dl) 0.4 (0.02-0.5) 0.1 (0.0-0.5) p=0.342
PASC Symptoms N(%) PASC Symptoms N(%) PASC Symptoms N(%) PASC Symptoms N(%) PASC Symptoms N(%)
Shortness of breath/exercise intolerance 12 (71) N/A N/A
Paresthesia 10 (59) N/A N/A
Smell/taste disturbance 7 (41) N/A N/A
Chest pain 6 (35) N/A N/A
Dyspnea 5 (29) N/A N/A
Headache 5 (29) N/A N/A
Concentration disturbance (brain fog) 5 (29) N/A N/A
Vertigo 4 (24) N/A N/A
Fatique 2 (12) N/A N/A
Diarrhea 2 (12) N/A N/A
Sleep disturbances 1 (6) N/A N/A
Sensory disorder 1 (6) N/A N/A
Palpitations 1 (6) N/A N/A
Abdominal pain 1 (6) N/A N/A
New diagnosis since COVID-19 New diagnosis since COVID-19 New diagnosis since COVID-19 New diagnosis since COVID-19 New diagnosis since COVID-19
Eating disorder 1 (6) N/A N/A
Depressive disorder 1 (6) N/A N/A
Asthma exacerbation 1 (6) N/A N/A
Increased susceptibility to infections 1 (6) N/A N/A
Instrumental Diagnostics N (%) Instrumental Diagnostics N (%) Instrumental Diagnostics N (%) Instrumental Diagnostics N (%) Instrumental Diagnostics N (%)
ECG 11 (65) 0 N/A
normal 11 (65) N/A N/A
NLG 11 (65) 0 N/A
normal 10 (65) N/A N/A
pathological 1 (6) N/A N/A
Echocardiogram 11 (65) 11 (85) N/A
EF normal 11 (65) 11 (85) N/A
mild TI 8 (47) 3 (27) 0.0861
mild AI 1 (6) 0 1
mild MI 0 2 (15) 0.476
Not relevant pericardial effusion 0 1 (8) 1
Lung function test 9 (53) 0 N/A
Ventilatory disorder 1 (6) N/A N/A
Bronchial hyperreactivity 1 (6) N/A N/A
Hyperinflation 1 (6) N/A N/A
Comorbidities Comorbidities Comorbidities Comorbidities Comorbidities
Asthma bronchiale 1 (6) 0 N/A